Cognosci, Inc.

Durham, NC Michael Vitek

UEI
NZW4KLUZ17G3
CAGE
43KD9
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3326 Durham-Chapel Hill Blvd, Durham, NC 27705, USA
Website
cognosci.com
Founded
2000
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel orally-available prodrugs for alzheimer's disease R43AG051285 National Institutes of Health $225,000
Antagonizing the set oncoprotein R43CA195879 National Institutes of Health $225,000
Inhibitor #2 of protein phosphatase 2A (I2PP2A) and asthma R43HL117399 National Institutes of Health $268,220
Neurorestorative strategy for diabetic peripheral neuropathy R43DK100139 National Institutes of Health $225,067
Investigational safety and toxicity studies of subcutaneous COG1410 for alzheimer R43AG044874 National Institutes of Health $273,242

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Cognosci, Inc. registered in SAM.gov?

Yes. Cognosci, Inc.'s SAM.gov registration is active through February 18, 2027.

What is Cognosci, Inc.'s most recent federal award?

Cognosci, Inc.'s most recent federal grant award is Novel orally-available prodrugs for alzheimer's disease (R43AG051285), from National Institutes of Health, on August 1, 2015.

On GovTribe

See Cognosci, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login